Commure Scales by Integrating Augmedix

The Augmedix deal matters because it shows Commure is not just buying revenue, it is stitching documentation, revenue cycle, and clinician workflow into one hospital sales motion. Augmedix added a scaled ambient documentation business, about $45M of 2023 revenue, while giving Commure another wedge into large health systems where it can later sell coding, billing, patient monitoring, and other software on the same contract footprint.

• Commure has been assembling a hospital stack through repeated M&A, including earlier products for patient lists, hiring, communication, PatientKeeper, Strongline, Athelas, and then Augmedix. That pattern suggests the company has built operating muscle around taking point solutions and making them interoperable instead of relying on clean industry APIs that barely exist in healthcare.
  1 sacra 2 sacra
• Augmedix brought more than a product. It brought enterprise ambient AI distribution. The company sold documentation tools into hospitals and large groups, then won a Vizient contract in January 2025 as a Commure subsidiary. That is the kind of channel expansion that makes an acquisition look integrated rather than merely absorbed.
  3 globenewswire 5 commure
• The strategic benchmark is Epic, not another note taking startup. Commure reached an estimated $105M ARR by March 2024 after the Athelas merger, and the Augmedix acquisition widened its product surface so hospitals can buy more modules from one vendor. In healthcare software, growth often comes from cross selling more workflows into the same health system, not just adding more seats.
  1 sacra 2 sacra 4 sacra

The next step is turning ambient AI from a single workflow into the front door for a broader hospital operating system. If Commure keeps embedding Augmedix into EHR connected products and channel deals, documentation becomes the land product and revenue cycle, care coordination, and operations automation become the expansion path.